English
简体中文
Total: £ 56.28
Published Date: 2025-01-21 | Pages: 91 | Tables: 91 | Pharma & Healthcare
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide.
The Budesonide market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Segment by Type
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Budesonide Market Overview
1.1 Product Definition
1.2 Budesonide by Type
1.2.1 Global Budesonide Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide by Application
1.3.1 Global Budesonide Market Value by Application (2024 VS 2031)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Global Budesonide Market Size Estimates and Forecasts
1.4.1 Global Budesonide Revenue 2020-2031
1.4.2 Global Budesonide Sales 2020-2031
1.4.3 Global Budesonide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Budesonide Market Competition by Manufacturers
2.1 Global Budesonide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Budesonide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Budesonide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Budesonide, Product Type & Application
2.7 Global Key Manufacturers of Budesonide, Date of Enter into This Industry
2.8 Global Budesonide Market Competitive Situation and Trends
2.8.1 Global Budesonide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Budesonide Players Market Share by Revenue
2.8.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Budesonide Market Scenario by Region
3.1 Global Budesonide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Budesonide Sales by Region: 2020-2031
3.2.1 Global Budesonide Sales by Region: 2020-2025
3.2.2 Global Budesonide Sales by Region: 2026-2031
3.3 Global Budesonide Revenue by Region: 2020-2031
3.3.1 Global Budesonide Revenue by Region: 2020-2025
3.3.2 Global Budesonide Revenue by Region: 2026-2031
3.4 North America Budesonide Market Facts & Figures by Country
3.4.1 North America Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Budesonide Sales by Country (2020-2031)
3.4.3 North America Budesonide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Market Facts & Figures by Country
3.5.1 Europe Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Budesonide Sales by Country (2020-2031)
3.5.3 Europe Budesonide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Market Facts & Figures by Region
3.6.1 Asia Pacific Budesonide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Budesonide Sales by Region (2020-2031)
3.6.3 Asia Pacific Budesonide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Budesonide Market Facts & Figures by Country
3.7.1 Latin America Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Budesonide Sales by Country (2020-2031)
3.7.3 Latin America Budesonide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Budesonide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Budesonide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Budesonide Sales by Type (2020-2031)
4.1.1 Global Budesonide Sales by Type (2020-2025)
4.1.2 Global Budesonide Sales by Type (2026-2031)
4.1.3 Global Budesonide Sales Market Share by Type (2020-2031)
4.2 Global Budesonide Revenue by Type (2020-2031)
4.2.1 Global Budesonide Revenue by Type (2020-2025)
4.2.2 Global Budesonide Revenue by Type (2026-2031)
4.2.3 Global Budesonide Revenue Market Share by Type (2020-2031)
4.3 Global Budesonide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Budesonide Sales by Application (2020-2031)
5.1.1 Global Budesonide Sales by Application (2020-2025)
5.1.2 Global Budesonide Sales by Application (2026-2031)
5.1.3 Global Budesonide Sales Market Share by Application (2020-2031)
5.2 Global Budesonide Revenue by Application (2020-2031)
5.2.1 Global Budesonide Revenue by Application (2020-2025)
5.2.2 Global Budesonide Revenue by Application (2026-2031)
5.2.3 Global Budesonide Revenue Market Share by Application (2020-2031)
5.3 Global Budesonide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sandoz Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Company Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Company Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Salix Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.7.1 Chiesi Farmaceutici Company Information
6.7.2 Chiesi Farmaceutici Description and Business Overview
6.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chiesi Farmaceutici Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Company Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Orion Corporation Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Company Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Synmosa Biopharma Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Company Information
6.11.2 Lunan Better Pharma Description and Business Overview
6.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lunan Better Pharma Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Company Information
6.12.2 Shanghai Sine Promod Description and Business Overview
6.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Sine Promod Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Industry Chain Analysis
7.2 Budesonide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Production Mode & Process Analysis
7.4 Budesonide Sales and Marketing
7.4.1 Budesonide Sales Channels
7.4.2 Budesonide Distributors
7.5 Budesonide Customer Analysis
8 Budesonide Market Dynamics
8.1 Budesonide Industry Trends
8.2 Budesonide Market Drivers
8.3 Budesonide Market Challenges
8.4 Budesonide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Budesonide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Budesonide Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Budesonide Market Competitive Situation by Manufacturers in 2024
Table 4. Global Budesonide Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Budesonide Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Budesonide Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Budesonide Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Budesonide Average Price (USD/K Units) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Budesonide, Product Type & Application
Table 12. Global Key Manufacturers of Budesonide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Budesonide Sales by Region (2020-2025) & (M Units)
Table 18. Global Budesonide Sales Market Share by Region (2020-2025)
Table 19. Global Budesonide Sales by Region (2026-2031) & (M Units)
Table 20. Global Budesonide Sales Market Share by Region (2026-2031)
Table 21. Global Budesonide Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Budesonide Revenue Market Share by Region (2020-2025)
Table 23. Global Budesonide Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Budesonide Revenue Market Share by Region (2026-2031)
Table 25. North America Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Budesonide Sales by Country (2020-2025) & (M Units)
Table 27. North America Budesonide Sales by Country (2026-2031) & (M Units)
Table 28. North America Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Budesonide Sales by Country (2020-2025) & (M Units)
Table 32. Europe Budesonide Sales by Country (2026-2031) & (M Units)
Table 33. Europe Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Budesonide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Budesonide Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Budesonide Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Budesonide Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Budesonide Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Budesonide Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Budesonide Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Budesonide Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Budesonide Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Budesonide Sales (M Units) by Type (2020-2025)
Table 51. Global Budesonide Sales (M Units) by Type (2026-2031)
Table 52. Global Budesonide Sales Market Share by Type (2020-2025)
Table 53. Global Budesonide Sales Market Share by Type (2026-2031)
Table 54. Global Budesonide Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Budesonide Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Budesonide Revenue Market Share by Type (2020-2025)
Table 57. Global Budesonide Revenue Market Share by Type (2026-2031)
Table 58. Global Budesonide Price (USD/K Units) by Type (2020-2025)
Table 59. Global Budesonide Price (USD/K Units) by Type (2026-2031)
Table 60. Global Budesonide Sales (M Units) by Application (2020-2025)
Table 61. Global Budesonide Sales (M Units) by Application (2026-2031)
Table 62. Global Budesonide Sales Market Share by Application (2020-2025)
Table 63. Global Budesonide Sales Market Share by Application (2026-2031)
Table 64. Global Budesonide Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Budesonide Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Budesonide Revenue Market Share by Application (2020-2025)
Table 67. Global Budesonide Revenue Market Share by Application (2026-2031)
Table 68. Global Budesonide Price (USD/K Units) by Application (2020-2025)
Table 69. Global Budesonide Price (USD/K Units) by Application (2026-2031)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 73. AstraZeneca Budesonide Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 78. Teva Budesonide Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 83. Mylan Budesonide Product
Table 84. Mylan Recent Developments/Updates
Table 85. Sandoz Company Information
Table 86. Sandoz Description and Business Overview
Table 87. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 88. Sandoz Budesonide Product
Table 89. Sandoz Recent Developments/Updates
Table 90. Cosmo Pharmaceuticals Company Information
Table 91. Cosmo Pharmaceuticals Description and Business Overview
Table 92. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 93. Cosmo Pharmaceuticals Budesonide Product
Table 94. Cosmo Pharmaceuticals Recent Developments/Updates
Table 95. Salix Company Information
Table 96. Salix Description and Business Overview
Table 97. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 98. Salix Budesonide Product
Table 99. Salix Recent Developments/Updates
Table 100. Chiesi Farmaceutici Company Information
Table 101. Chiesi Farmaceutici Description and Business Overview
Table 102. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 103. Chiesi Farmaceutici Budesonide Product
Table 104. Chiesi Farmaceutici Recent Developments/Updates
Table 105. Orion Corporation Company Information
Table 106. Orion Corporation Description and Business Overview
Table 107. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 108. Orion Corporation Budesonide Product
Table 109. Orion Corporation Recent Developments/Updates
Table 110. Cipla Company Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 113. Cipla Budesonide Product
Table 114. Cipla Recent Developments/Updates
Table 115. Synmosa Biopharma Company Information
Table 116. Synmosa Biopharma Description and Business Overview
Table 117. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 118. Synmosa Biopharma Budesonide Product
Table 119. Synmosa Biopharma Recent Developments/Updates
Table 120. Lunan Better Pharma Company Information
Table 121. Lunan Better Pharma Description and Business Overview
Table 122. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 123. Lunan Better Pharma Budesonide Product
Table 124. Lunan Better Pharma Recent Developments/Updates
Table 125. Shanghai Sine Promod Company Information
Table 126. Shanghai Sine Promod Description and Business Overview
Table 127. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 128. Shanghai Sine Promod Budesonide Product
Table 129. Shanghai Sine Promod Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Budesonide Distributors List
Table 133. Budesonide Customers List
Table 134. Budesonide Market Trends
Table 135. Budesonide Market Drivers
Table 136. Budesonide Market Challenges
Table 137. Budesonide Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Budesonide
Figure 2. Global Budesonide Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Budesonide Market Share by Type: 2024 & 2031
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Budesonide Market Share by Application: 2024 & 2031
Figure 10. Respiratory Disease Treatment
Figure 11. Nose Disease Treatment
Figure 12. Inflammatory Bowel Disease Treatment
Figure 13. Others
Figure 14. Global Budesonide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Budesonide Market Size (2020-2031) & (US$ Million)
Figure 16. Global Budesonide Sales (2020-2031) & (M Units)
Figure 17. Global Budesonide Average Price (USD/K Units) & (2020-2031)
Figure 18. Budesonide Report Years Considered
Figure 19. Budesonide Sales Share by Manufacturers in 2024
Figure 20. Global Budesonide Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Budesonide Players: Market Share by Revenue in Budesonide in 2024
Figure 22. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Budesonide Sales Market Share by Country (2020-2031)
Figure 25. North America Budesonide Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Budesonide Sales Market Share by Country (2020-2031)
Figure 29. Europe Budesonide Revenue Market Share by Country (2020-2031)
Figure 30. Germany Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Budesonide Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Budesonide Revenue Market Share by Region (2020-2031)
Figure 37. China Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Budesonide Sales Market Share by Country (2020-2031)
Figure 48. Latin America Budesonide Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Budesonide Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Budesonide Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. U.A.E Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Budesonide by Type (2020-2031)
Figure 58. Global Revenue Market Share of Budesonide by Type (2020-2031)
Figure 59. Global Budesonide Price (USD/K Units) by Type (2020-2031)
Figure 60. Global Sales Market Share of Budesonide by Application (2020-2031)
Figure 61. Global Revenue Market Share of Budesonide by Application (2020-2031)
Figure 62. Global Budesonide Price (USD/K Units) by Application (2020-2031)
Figure 63. Budesonide Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
